STOCK TITAN

[Form 4] Soluna Holdings, Inc 9.0% Series A Cumulative Perpetual Preferred Stock Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Soluna Holdings director William Hazelip received a grant of 99,679 restricted stock awards on 09/01/2025, increasing his reported beneficial ownership to 291,384 shares of Common Stock. The awards were approved by the Compensation Committee and carry a reported price of $0. The restricted shares are structured to vest 100% upon the reporting person9s separation from the issuer. The Form 4 was signed by an attorney-in-fact on 09/02/2025 and reports the transaction as a non-derivative acquisition under Section 16.

Il direttore di Soluna Holdings, William Hazelip, ha ricevuto in data 01/09/2025 una sovvenzione di 99.679 restricted stock awards, portando la sua partecipazione beneficiaria dichiarata a 291.384 azioni di Common Stock. Le assegnazioni sono state approvate dal Compensation Committee e risultano avere un prezzo riportato pari a $0. Le azioni vincolate sono strutturate per maturare al 100% al momento della separazione della persona segnalante dall'emittente. Il Modulo 4 è stato firmato da un procuratore il 02/09/2025 e dichiara la transazione come un'acquisizione non derivata ai sensi della Sezione 16.

El director de Soluna Holdings, William Hazelip, recibió el 01/09/2025 una concesión de 99.679 restricted stock awards, elevando su propiedad beneficiaria informada a 291.384 acciones de Common Stock. Las adjudicaciones fueron aprobadas por el Comité de Compensación y figuran con un precio informado de $0. Las acciones restringidas están estructuradas para consolidarse al 100% cuando la persona informante se separe del emisor. El Formulario 4 fue firmado por un apoderado el 02/09/2025 y reporta la operación como una adquisición no derivada conforme a la Sección 16.

Soluna Holdings 이사 윌리엄 헤이젤립은 2025-09-01에 99,679주의 제한주식(Restricted Stock Awards)을 수여받아 신고된 실질 보유 주식 수가 보통주 291,384주로 늘어났습니다. 이 수여는 보상위원회(Compensation Committee)의 승인을 받았으며 신고된 가격은 $0입니다. 제한 주식은 신고인이 발행사와 분리될 때 100% 베스트(권리확정)되도록 구조화되어 있습니다. Form 4는 2025-09-02에 법정대리인이 서명했으며 해당 거래를 섹션 16에 따른 비파생(non-derivative) 취득으로 보고하고 있습니다.

Le directeur de Soluna Holdings, William Hazelip, a reçu le 01/09/2025 une attribution de 99 679 restricted stock awards, portant sa participation bénéficiaire déclarée à 291 384 actions ordinaires. Les attributions ont été approuvées par le Compensation Committee et sont indiquées à un prix déclaré de 0 $. Les actions restreintes sont structurées pour devenir acquises à 100 % lors de la séparation de la personne déclarante de l'émetteur. Le formulaire 4 a été signé par un mandataire le 02/09/2025 et rapporte la transaction comme une acquisition non dérivative au titre de la Section 16.

Der Direktor von Soluna Holdings, William Hazelip, erhielt am 01.09.2025 eine Zuweisung von 99.679 Restricted Stock Awards, wodurch sein gemeldetes wirtschaftliches Eigentum auf 291.384 Aktien der Stammaktien anstieg. Die Zuteilungen wurden vom Compensation Committee genehmigt und weisen einen gemeldeten Preis von $0 aus. Die eingeschränkten Aktien sind so gestaltet, dass sie zu 100% beim Ausscheiden der meldenden Person vom Emittenten unverfallbar werden. Das Formular 4 wurde am 02.09.2025 von einem Bevollmächtigten unterzeichnet und meldet die Transaktion als nicht-derivativen Erwerb gemäß Abschnitt 16.

Positive
  • Director alignment: Grant increases William Hazelip9s beneficial ownership to 291,384 shares, aligning his interests with shareholders
  • Committee approval: Awards were approved by the Compensation Committee, indicating formal governance review
Negative
  • Potential dilution: Grant of 99,679 restricted shares is dilutive to existing shareholders absent offsetting retirements or repurchases
  • Unusual vesting trigger: Vesting 100% upon separation is atypical and may indicate deferred/retention treatment rather than performance alignment

Insights

TL;DR: Director received a sizable restricted stock grant that vests on separation, aligning incentives but raising dilution questions.

The grant of 99,679 restricted shares is a conventional compensation tool to align a director9s interests with shareholders. Vesting tied to separation (100% upon separation) is atypical compared with time- or performance-based schedules and may indicate retention or deferred compensation treatment. The reported $0 price confirms these are awards rather than purchases. For governance review, note disclosure clarity on forfeiture conditions and whether similar awards were granted to peers.

TL;DR: The transaction is a non-cash equity grant increasing insider ownership to 291,384 shares; impact on financials is likely immaterial but dilutive.

This Form 4 shows a director-level equity grant approved by the Compensation Committee. While the award increases the director9s reported stake, the absolute size relative to total shares outstanding is not disclosed here, so materiality to EPS or ownership percentages cannot be determined from this filing alone. Treat this as routine insider compensation unless aggregated with other awards disclosed elsewhere.

Il direttore di Soluna Holdings, William Hazelip, ha ricevuto in data 01/09/2025 una sovvenzione di 99.679 restricted stock awards, portando la sua partecipazione beneficiaria dichiarata a 291.384 azioni di Common Stock. Le assegnazioni sono state approvate dal Compensation Committee e risultano avere un prezzo riportato pari a $0. Le azioni vincolate sono strutturate per maturare al 100% al momento della separazione della persona segnalante dall'emittente. Il Modulo 4 è stato firmato da un procuratore il 02/09/2025 e dichiara la transazione come un'acquisizione non derivata ai sensi della Sezione 16.

El director de Soluna Holdings, William Hazelip, recibió el 01/09/2025 una concesión de 99.679 restricted stock awards, elevando su propiedad beneficiaria informada a 291.384 acciones de Common Stock. Las adjudicaciones fueron aprobadas por el Comité de Compensación y figuran con un precio informado de $0. Las acciones restringidas están estructuradas para consolidarse al 100% cuando la persona informante se separe del emisor. El Formulario 4 fue firmado por un apoderado el 02/09/2025 y reporta la operación como una adquisición no derivada conforme a la Sección 16.

Soluna Holdings 이사 윌리엄 헤이젤립은 2025-09-01에 99,679주의 제한주식(Restricted Stock Awards)을 수여받아 신고된 실질 보유 주식 수가 보통주 291,384주로 늘어났습니다. 이 수여는 보상위원회(Compensation Committee)의 승인을 받았으며 신고된 가격은 $0입니다. 제한 주식은 신고인이 발행사와 분리될 때 100% 베스트(권리확정)되도록 구조화되어 있습니다. Form 4는 2025-09-02에 법정대리인이 서명했으며 해당 거래를 섹션 16에 따른 비파생(non-derivative) 취득으로 보고하고 있습니다.

Le directeur de Soluna Holdings, William Hazelip, a reçu le 01/09/2025 une attribution de 99 679 restricted stock awards, portant sa participation bénéficiaire déclarée à 291 384 actions ordinaires. Les attributions ont été approuvées par le Compensation Committee et sont indiquées à un prix déclaré de 0 $. Les actions restreintes sont structurées pour devenir acquises à 100 % lors de la séparation de la personne déclarante de l'émetteur. Le formulaire 4 a été signé par un mandataire le 02/09/2025 et rapporte la transaction comme une acquisition non dérivative au titre de la Section 16.

Der Direktor von Soluna Holdings, William Hazelip, erhielt am 01.09.2025 eine Zuweisung von 99.679 Restricted Stock Awards, wodurch sein gemeldetes wirtschaftliches Eigentum auf 291.384 Aktien der Stammaktien anstieg. Die Zuteilungen wurden vom Compensation Committee genehmigt und weisen einen gemeldeten Preis von $0 aus. Die eingeschränkten Aktien sind so gestaltet, dass sie zu 100% beim Ausscheiden der meldenden Person vom Emittenten unverfallbar werden. Das Formular 4 wurde am 02.09.2025 von einem Bevollmächtigten unterzeichnet und meldet die Transaktion als nicht-derivativen Erwerb gemäß Abschnitt 16.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hazelip William

(Last) (First) (Middle)
C/O SOLUNA HOLDINGS, INC.
325 WASHINGTON AVENUE EXTENSION

(Street)
ALBANY NY 12205

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Soluna Holdings, Inc [ SLNH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/01/2025 A 99,679(1) A $0 291,384 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Transaction reported is a grant of 99,679 restricted stock awards representing shares of Common Stock, par value $0.001 per share, of the issuer ("Common Stock"), which were approved by the Compensation Committee. The shares of Common Stock will vest 100% upon the reporting person's separation from the issuer.
/s/ Christopher Gandolfo, Attorney in Fact 09/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did William Hazelip report on Form 4 for Soluna Holdings (SLNH)?

He reported a grant of 99,679 restricted stock awards on 09/01/2025, increasing his beneficial ownership to 291,384 shares.

What are the vesting terms of the restricted stock awarded to the director?

The restricted shares are reported to vest 100% upon the reporting person9s separation from the issuer.

What price was reported for the restricted stock award?

The transaction is reported with a price of $0, indicating the shares were granted rather than purchased.

Who approved the restricted stock awards for Soluna Holdings?

The awards were approved by the company9s Compensation Committee according to the filing.

When was the Form 4 filed and signed?

The Form 4 shows the transaction date as 09/01/2025 and was signed by an attorney-in-fact on 09/02/2025.
SOLUNA HOLDINGS INC

NASDAQ:SLNHP

SLNHP Rankings

SLNHP Latest News

SLNHP Latest SEC Filings

SLNHP Stock Data

3.06M
9.46%
Capital Markets
Finance Services
Link
United States
ALBANY